ICAAC/IDSA 2008

A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube
48th ICAAC/IDSA 46th Annual Meeting
ICAAC/IDSA 2008 48th ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008

Starting & Switching Treatment

Experimental HIV Drugs
October 28, 2008

New NNRTI Called RDEA806 Shows Promise
Once-daily RDEA806, an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) being developed by Ardea Biosciences, appears highly active against HIV, is unlikely to have significant interactions with other meds and may have a useful side effect—reducing uric acid levels.




People who have lived with HIV/AIDS for 25 years or more are battle-scarred and full of survival savvy. Click here to read more about their stories.
HIV Transmission & Prevention

HIV/AIDS Complications

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.